EW
Edwards Lifesciences Corporation
Stock
$85.15−0.04 (−0.05%)Close Oct 2, 2026
- Free cash flow, 2025
- $1.3B
- YoY, 2025
- +360.5%
- 5-year CAGR
- +15.6%
- 10-year CAGR
- +11.6%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $1.3B | +360.5% |
| 2024 | $290M | −54.9% |
| 2023 | $643M | −34.0% |
| 2022 | $974M | −30.8% |
| 2021 | $1.4B | +117.3% |
| 2020 | $647M | −30.3% |
| 2019 | $929M | +35.0% |
| 2018 | $688M | −17.4% |
| 2017 | $833M | +57.6% |
| 2016 | $528M | +18.2% |
| 2015 | $447M | −52.4% |
| 2014 | $939M | +158.3% |
| 2013 | $364M | +43.7% |
| 2012 | $253M | +9.3% |
| 2011 | $232M | +22.2% |
| 2010 | $190M | +87.2% |
| 2009 | $101M | −1.3% |
| 2008 | $103M | — |